Bactiguard Holding AB (CHIX:BACTBS) Forward Dividend Yield %: 0.00% (As of Jun. 26, 2026)


CHIX:BACTBS Bactiguard Holding AB CHIX:BACTBS
52 GF Score
Price kr128.60
GF Value kr264.39
! 3 Warning Signs
View Full Analysis

What is Bactiguard Holding AB Forward Dividend Yield %?

Bactiguard Holding AB CHIX:BACTBS 52 Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates CHIX:BACTBS with a GF Score™ of 52/100 and a GF Value™ of kr264.39. The stock has 3 warning signs investors should review. Among 316 Medical Devices & Instruments companies, Bactiguard Holding AB ranks worse than 316455.38% on this metric.

As of today (2026-06-26), the Forward Annual Dividend Yield of Bactiguard Holding AB is 0.00%.

As of today (2026-06-26), the Trailing Annual Dividend Yield of Bactiguard Holding AB is 0.00%.

CHIX:BACTBs's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.09
* Ranked among companies with meaningful Forward Dividend Yield % only.

Bactiguard Holding AB's Dividends per Share for the three months ended in Mar. 2026 was kr0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Bactiguard Holding AB  (CHIX:BACTBs) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Bactiguard Holding AB Forward Dividend Yield % Related Terms


CHIX:BACTBS vs ABT, SYK, MDT: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, Bactiguard Holding AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bactiguard Holding AB Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Bactiguard Holding AB's Forward Dividend Yield % falls into.


CHIX:BACTBS
52GF Score
Bactiguard Holding AB CHIX:BACTBS
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bactiguard Holding AB Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Bactiguard Holding AB (CHIX:BACTBS) has a Forward Dividend Yield % of 0.00% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Bactiguard Holding AB and its competitors. According to the industry distribution chart, Bactiguard Holding AB ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is Bactiguard Holding AB's Forward Dividend Yield % too high?
Bactiguard Holding AB's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Bactiguard Holding AB ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bactiguard Holding AB has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #999999 out of 316 companies for Forward Dividend Yield %. This places Bactiguard Holding AB in the lower half of its industry. The industry median Forward Dividend Yield % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.09, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Bactiguard Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bactiguard Holding AB's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Forward Dividend Yield % of 0.00%. The stock's GF Value™ is kr264.39, compared to a current price of kr128.60 — trading 51.4% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Bactiguard Holding AB's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?

Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued. The current stock price of kr128.60 is trading 51.4% below its estimated GF Value™ of kr264.39.

Key valuation signals for CHIX:BACTBS:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: kr264.39 vs. price of kr128.60 (51.4% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bactiguard Holding AB Business Description

Other Exchanges BACTI B:Sweden5JE:Germany
Address Vasagatan 11, Stockholm, SWE, 111 20
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
52GF Score

Get the complete analysis for CHIX:BACTBS

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr128.60
Price
kr264.39
GF Value